This report contains market size and forecasts of Electrocompetent Cells in Global, including the following market information:
Global Electrocompetent Cells Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Electrocompetent Cells market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Electrocompetent Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Electrocompetent Cells Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Electrocompetent Cells Market Segment Percentages, By Type, 2020 (%)
Cloned Competent Cells
Agrobacterium tumefaciens Competent Cells
Expression Competent Cells
China Electrocompetent Cells Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Electrocompetent Cells Market Segment Percentages, By Application, 2020 (%)
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable Dna Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded Dna Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)
Global Electrocompetent Cells Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Electrocompetent Cells Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Electrocompetent Cells Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Electrocompetent Cells Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Electrocompetent Cells Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Electrocompetent Cells Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Electrocompetent Cells Overall Market Size
2.1 Global Electrocompetent Cells Market Size: 2021 VS 2027
2.2 Global Electrocompetent Cells Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Electrocompetent Cells Players in Global Market
3.2 Top Global Electrocompetent Cells Companies Ranked by Revenue
3.3 Global Electrocompetent Cells Revenue by Companies
3.4 Top 3 and Top 5 Electrocompetent Cells Companies in Global Market, by Revenue in 2020
3.5 Global Companies Electrocompetent Cells Product Type
3.6 Tier 1, Tier 2 and Tier 3 Electrocompetent Cells Players in Global Market
3.6.1 List of Global Tier 1 Electrocompetent Cells Companies
3.6.2 List of Global Tier 2 and Tier 3 Electrocompetent Cells Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Electrocompetent Cells Market Size Markets, 2021 & 2027
4.1.2 Cloned Competent Cells
4.1.3 Agrobacterium tumefaciens Competent Cells
4.1.4 Expression Competent Cells
4.2 By Type - Global Electrocompetent Cells Revenue & Forecasts
4.2.1 By Type - Global Electrocompetent Cells Revenue, 2016-2021
4.2.2 By Type - Global Electrocompetent Cells Revenue, 2022-2027
4.2.3 By Type - Global Electrocompetent Cells Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Electrocompetent Cells Market Size, 2021 & 2027
5.1.2 Subcloning & Routine Cloning
5.1.3 Phage Display Library Construction
5.1.4 Toxic/Unstable Dna Cloning
5.1.5 High-Throughput Cloning
5.1.6 Protein Expression
5.1.7 Mutagenesis
5.1.8 Single-Stranded Dna Production
5.1.9 Bacmid creation
5.1.10 Cre-lox recombination (PIR1/PIR2)
5.2 By Application - Global Electrocompetent Cells Revenue & Forecasts
5.2.1 By Application - Global Electrocompetent Cells Revenue, 2016-2021
5.2.2 By Application - Global Electrocompetent Cells Revenue, 2022-2027
5.2.3 By Application - Global Electrocompetent Cells Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Electrocompetent Cells Market Size, 2021 & 2027
6.2 By Region - Global Electrocompetent Cells Revenue & Forecasts
6.2.1 By Region - Global Electrocompetent Cells Revenue, 2016-2021
6.2.2 By Region - Global Electrocompetent Cells Revenue, 2022-2027
6.2.3 By Region - Global Electrocompetent Cells Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Electrocompetent Cells Revenue, 2016-2027
6.3.2 US Electrocompetent Cells Market Size, 2016-2027
6.3.3 Canada Electrocompetent Cells Market Size, 2016-2027
6.3.4 Mexico Electrocompetent Cells Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Electrocompetent Cells Revenue, 2016-2027
6.4.2 Germany Electrocompetent Cells Market Size, 2016-2027
6.4.3 France Electrocompetent Cells Market Size, 2016-2027
6.4.4 U.K. Electrocompetent Cells Market Size, 2016-2027
6.4.5 Italy Electrocompetent Cells Market Size, 2016-2027
6.4.6 Russia Electrocompetent Cells Market Size, 2016-2027
6.4.7 Nordic Countries Electrocompetent Cells Market Size, 2016-2027
6.4.8 Benelux Electrocompetent Cells Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Electrocompetent Cells Revenue, 2016-2027
6.5.2 China Electrocompetent Cells Market Size, 2016-2027
6.5.3 Japan Electrocompetent Cells Market Size, 2016-2027
6.5.4 South Korea Electrocompetent Cells Market Size, 2016-2027
6.5.5 Southeast Asia Electrocompetent Cells Market Size, 2016-2027
6.5.6 India Electrocompetent Cells Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Electrocompetent Cells Revenue, 2016-2027
6.6.2 Brazil Electrocompetent Cells Market Size, 2016-2027
6.6.3 Argentina Electrocompetent Cells Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Electrocompetent Cells Revenue, 2016-2027
6.7.2 Turkey Electrocompetent Cells Market Size, 2016-2027
6.7.3 Israel Electrocompetent Cells Market Size, 2016-2027
6.7.4 Saudi Arabia Electrocompetent Cells Market Size, 2016-2027
6.7.5 UAE Electrocompetent Cells Market Size, 2016-2027
7 Players Profiles
7.1 Merck KGaA
7.1.1 Merck KGaA Corporate Summary
7.1.2 Merck KGaA Business Overview
7.1.3 Merck KGaA Electrocompetent Cells Major Product Offerings
7.1.4 Merck KGaA Electrocompetent Cells Revenue in Global (2016-2021)
7.1.5 Merck KGaA Key News
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Corporate Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Electrocompetent Cells Major Product Offerings
7.2.4 Thermo Fisher Scientific Electrocompetent Cells Revenue in Global (2016-2021)
7.2.5 Thermo Fisher Scientific Key News
7.3 Agilent Technologies
7.3.1 Agilent Technologies Corporate Summary
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies Electrocompetent Cells Major Product Offerings
7.3.4 Agilent Technologies Electrocompetent Cells Revenue in Global (2016-2021)
7.3.5 Agilent Technologies Key News
7.4 Takara Bio
7.4.1 Takara Bio Corporate Summary
7.4.2 Takara Bio Business Overview
7.4.3 Takara Bio Electrocompetent Cells Major Product Offerings
7.4.4 Takara Bio Electrocompetent Cells Revenue in Global (2016-2021)
7.4.5 Takara Bio Key News
7.5 Promega Corporation
7.5.1 Promega Corporation Corporate Summary
7.5.2 Promega Corporation Business Overview
7.5.3 Promega Corporation Electrocompetent Cells Major Product Offerings
7.5.4 Promega Corporation Electrocompetent Cells Revenue in Global (2016-2021)
7.5.5 Promega Corporation Key News
7.6 Beijing TransGen Biotech
7.6.1 Beijing TransGen Biotech Corporate Summary
7.6.2 Beijing TransGen Biotech Business Overview
7.6.3 Beijing TransGen Biotech Electrocompetent Cells Major Product Offerings
7.6.4 Beijing TransGen Biotech Electrocompetent Cells Revenue in Global (2016-2021)
7.6.5 Beijing TransGen Biotech Key News
7.7 GeneScript Corporation
7.7.1 GeneScript Corporation Corporate Summary
7.7.2 GeneScript Corporation Business Overview
7.7.3 GeneScript Corporation Electrocompetent Cells Major Product Offerings
7.4.4 GeneScript Corporation Electrocompetent Cells Revenue in Global (2016-2021)
7.7.5 GeneScript Corporation Key News
7.8 Yeastern Biotech
7.8.1 Yeastern Biotech Corporate Summary
7.8.2 Yeastern Biotech Business Overview
7.8.3 Yeastern Biotech Electrocompetent Cells Major Product Offerings
7.8.4 Yeastern Biotech Electrocompetent Cells Revenue in Global (2016-2021)
7.8.5 Yeastern Biotech Key News
7.9 New England Biolabs
7.9.1 New England Biolabs Corporate Summary
7.9.2 New England Biolabs Business Overview
7.9.3 New England Biolabs Electrocompetent Cells Major Product Offerings
7.9.4 New England Biolabs Electrocompetent Cells Revenue in Global (2016-2021)
7.9.5 New England Biolabs Key News
7.10 QIAGEN N.V.
7.10.1 QIAGEN N.V. Corporate Summary
7.10.2 QIAGEN N.V. Business Overview
7.10.3 QIAGEN N.V. Electrocompetent Cells Major Product Offerings
7.10.4 QIAGEN N.V. Electrocompetent Cells Revenue in Global (2016-2021)
7.10.5 QIAGEN N.V. Key News
7.11 OriGene Technologies
7.11.1 OriGene Technologies Corporate Summary
7.11.2 OriGene Technologies Business Overview
7.11.3 OriGene Technologies Electrocompetent Cells Major Product Offerings
7.11.4 OriGene Technologies Electrocompetent Cells Revenue in Global (2016-2021)
7.11.5 OriGene Technologies Key News
7.12 Lucigen
7.12.1 Lucigen Corporate Summary
7.12.2 Lucigen Business Overview
7.12.3 Lucigen Electrocompetent Cells Major Product Offerings
7.12.4 Lucigen Electrocompetent Cells Revenue in Global (2016-2021)
7.12.5 Lucigen Key News
7.13 Zymo Research
7.13.1 Zymo Research Corporate Summary
7.13.2 Zymo Research Business Overview
7.13.3 Zymo Research Electrocompetent Cells Major Product Offerings
7.13.4 Zymo Research Electrocompetent Cells Revenue in Global (2016-2021)
7.13.5 Zymo Research Key News
7.14 Bio-Rad Laboratories
7.14.1 Bio-Rad Laboratories Corporate Summary
7.14.2 Bio-Rad Laboratories Business Overview
7.14.3 Bio-Rad Laboratories Electrocompetent Cells Major Product Offerings
7.14.4 Bio-Rad Laboratories Electrocompetent Cells Revenue in Global (2016-2021)
7.14.5 Bio-Rad Laboratories Key News
7.15 Bioline
7.15.1 Bioline Corporate Summary
7.15.2 Bioline Business Overview
7.15.3 Bioline Electrocompetent Cells Major Product Offerings
7.15.4 Bioline Electrocompetent Cells Revenue in Global (2016-2021)
7.15.5 Bioline Key News
7.16 Delphi Genetics
7.16.1 Delphi Genetics Corporate Summary
7.16.2 Delphi Genetics Business Overview
7.16.3 Delphi Genetics Electrocompetent Cells Major Product Offerings
7.16.4 Delphi Genetics Electrocompetent Cells Revenue in Global (2016-2021)
7.16.5 Delphi Genetics Key News
7.17 IBA GmBH
7.17.1 IBA GmBH Corporate Summary
7.17.2 IBA GmBH Business Overview
7.17.3 IBA GmBH Electrocompetent Cells Major Product Offerings
7.17.4 IBA GmBH Electrocompetent Cells Revenue in Global (2016-2021)
7.17.5 IBA GmBH Key News
7.18 Cell Applications
7.18.1 Cell Applications Corporate Summary
7.18.2 Cell Applications Business Overview
7.18.3 Cell Applications Electrocompetent Cells Major Product Offerings
7.18.4 Cell Applications Electrocompetent Cells Revenue in Global (2016-2021)
7.18.5 Cell Applications Key News
7.19 BioDynamics Laboratory
7.19.1 BioDynamics Laboratory Corporate Summary
7.19.2 BioDynamics Laboratory Business Overview
7.19.3 BioDynamics Laboratory Electrocompetent Cells Major Product Offerings
7.19.4 BioDynamics Laboratory Electrocompetent Cells Revenue in Global (2016-2021)
7.19.5 BioDynamics Laboratory Key News
7.20 Scarab Genomics
7.20.1 Scarab Genomics Corporate Summary
7.20.2 Scarab Genomics Business Overview
7.20.3 Scarab Genomics Electrocompetent Cells Major Product Offerings
7.20.4 Scarab Genomics Electrocompetent Cells Revenue in Global (2016-2021)
7.20.5 Scarab Genomics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Electrocompetent Cells Market Opportunities & Trends in Global Market
Table 2. Electrocompetent Cells Market Drivers in Global Market
Table 3. Electrocompetent Cells Market Restraints in Global Market
Table 4. Key Players of Electrocompetent Cells in Global Market
Table 5. Top Electrocompetent Cells Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Electrocompetent Cells Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Electrocompetent Cells Revenue Share by Companies, 2016-2021
Table 8. Global Companies Electrocompetent Cells Product Type
Table 9. List of Global Tier 1 Electrocompetent Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Electrocompetent Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics